JP2013507374A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013507374A5 JP2013507374A5 JP2012533276A JP2012533276A JP2013507374A5 JP 2013507374 A5 JP2013507374 A5 JP 2013507374A5 JP 2012533276 A JP2012533276 A JP 2012533276A JP 2012533276 A JP2012533276 A JP 2012533276A JP 2013507374 A5 JP2013507374 A5 JP 2013507374A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- substituted
- amino group
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 125000003277 amino group Chemical group 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 125000004193 piperazinyl group Chemical group 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 2
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 206010013663 drug dependence Diseases 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000002757 morpholinyl group Chemical group 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 201000000980 schizophrenia Diseases 0.000 claims 2
- 208000011117 substance-related disease Diseases 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- 208000006888 Agnosia Diseases 0.000 claims 1
- 241001047040 Agnosia Species 0.000 claims 1
- 208000027534 Emotional disease Diseases 0.000 claims 1
- 208000019022 Mood disease Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 0 *C(c1ccc(*)cc1)NC(C(*)(*)CCCCC1(*)*CCCCC1)=O Chemical compound *C(c1ccc(*)cc1)NC(C(*)(*)CCCCC1(*)*CCCCC1)=O 0.000 description 4
- GGWLBUSTVKFDCR-LFABVHOISA-N CCCC(C)COc1ccc([C@H](CN)NC(Cc2ccccc2)=O)cc1 Chemical compound CCCC(C)COc1ccc([C@H](CN)NC(Cc2ccccc2)=O)cc1 GGWLBUSTVKFDCR-LFABVHOISA-N 0.000 description 1
- SJAYUJIAILANNS-XGCAABAXSA-N CCCC(C)COc1ccc([C@H](CNCC2(CCCC2)N)NC(Cc2ccccc2)=O)cc1 Chemical compound CCCC(C)COc1ccc([C@H](CNCC2(CCCC2)N)NC(Cc2ccccc2)=O)cc1 SJAYUJIAILANNS-XGCAABAXSA-N 0.000 description 1
- FVDFNPOATWWMLW-KUXBLMNESA-N CCCC(C)COc1ccc([C@H](CNCC2CC2)NC(Cc2ccccc2)=O)cc1 Chemical compound CCCC(C)COc1ccc([C@H](CNCC2CC2)NC(Cc2ccccc2)=O)cc1 FVDFNPOATWWMLW-KUXBLMNESA-N 0.000 description 1
- XETOLXKBCRLLCB-JXFKEZNVSA-N CC[C@H](C)COc1ccc([C@H](CN)NC(Cc2ccccc2)=O)cc1 Chemical compound CC[C@H](C)COc1ccc([C@H](CN)NC(Cc2ccccc2)=O)cc1 XETOLXKBCRLLCB-JXFKEZNVSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25022909P | 2009-10-09 | 2009-10-09 | |
| US61/250,229 | 2009-10-09 | ||
| PCT/US2010/051614 WO2011044225A1 (en) | 2009-10-09 | 2010-10-06 | Modulators of g protein-coupled receptor 88 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013507374A JP2013507374A (ja) | 2013-03-04 |
| JP2013507374A5 true JP2013507374A5 (enExample) | 2013-11-21 |
Family
ID=43447064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012533276A Withdrawn JP2013507374A (ja) | 2009-10-09 | 2010-10-06 | Ｇタンパク質共役受容体８８の修飾因子 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8304577B2 (enExample) |
| EP (1) | EP2486011B1 (enExample) |
| JP (1) | JP2013507374A (enExample) |
| CN (1) | CN102656145A (enExample) |
| WO (1) | WO2011044225A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8497271B2 (en) | 2009-10-07 | 2013-07-30 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
| US8426414B2 (en) | 2009-10-09 | 2013-04-23 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
| EP2872161B1 (en) | 2012-06-26 | 2020-12-16 | Del Mar Pharmaceuticals | Dianhydrogalactitol for use in treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations |
| CN103020555B (zh) * | 2012-09-29 | 2015-04-08 | 东莞市依时利科技有限公司 | 一种rfid区域定位方法及定位系统 |
| JP2016523963A (ja) | 2013-07-08 | 2016-08-12 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | アリールアミドキナーゼ阻害剤 |
| EP3054955B1 (en) | 2013-10-11 | 2018-05-30 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| DE202015102728U1 (de) | 2014-12-17 | 2015-06-15 | Agco International Gmbh | Erntegutverarbeitungsrotor eines Mähdreschers mit einer Antiaufwickeleinrichtung |
| DE202015102726U1 (de) | 2014-12-17 | 2015-06-15 | Agco International Gmbh | Erntegutverarbeitungsrotor eines Mähdreschers mit einer Antiaufwickeleinrichtung |
| DE202015102727U1 (de) | 2014-12-17 | 2015-06-15 | Agco International Gmbh | Erntegutverarbeitungsrotor eines Mähdreschers mit einer Antiaufwickeleinrichtung |
| EP4469431A1 (en) * | 2022-01-25 | 2024-12-04 | Research Triangle Institute | 4-substituted-phenyl acetamides and arylureas as agonists for the orphan receptor gpr88 |
| GB202209193D0 (en) | 2022-06-22 | 2022-08-10 | Pandeia Therapeutics Ltd | Modulators of g protein-coupled receptor 88 |
| GB202209195D0 (en) | 2022-06-22 | 2022-08-10 | Pandeia Therapeutics Ltd | Modulators of g protein-coupled receptor 88 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2400368A1 (en) | 1992-12-02 | 1994-06-09 | Allen J. Duplantier | Catechol diethers as selective pde iv inhibitors |
| US5709861A (en) | 1993-04-22 | 1998-01-20 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
| EP1495009B1 (en) | 2002-04-05 | 2008-03-12 | Boehringer Ingelheim Pharmaceuticals Inc. | Cyanamides useful as reversible inhibitors of cysteine proteases |
| WO2003103666A2 (en) | 2002-06-07 | 2003-12-18 | Altana Pharma Ag | Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones |
| AU2003295781A1 (en) | 2002-11-22 | 2004-06-18 | Bristol-Myers Squibb Company | Arylcyclopropylcarboxylic amides as potassium channel openers |
| WO2004056744A1 (en) * | 2002-12-23 | 2004-07-08 | Janssen Pharmaceutica N.V. | Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| WO2004072018A1 (ja) | 2003-02-12 | 2004-08-26 | Takeda Pharmaceutical Company Limited | アミン誘導体 |
| WO2005000309A2 (en) | 2003-06-27 | 2005-01-06 | Ionix Pharmaceuticals Limited | Chemical compounds |
| US7834013B2 (en) | 2003-11-19 | 2010-11-16 | Glaxosmithkline Llc | Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40 |
| CA2570694A1 (en) | 2004-06-24 | 2006-02-02 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| JP2008512417A (ja) | 2004-09-10 | 2008-04-24 | ユセベ ファルマ ソシエテ アノニム | シグマ受容体リガンド |
| CN100494167C (zh) | 2005-08-02 | 2009-06-03 | 天津大学 | 抗乙肝病毒的叔胺氧化物及制备方法和制备药物的应用 |
| JP2007217408A (ja) | 2006-01-19 | 2007-08-30 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| GB0606202D0 (en) * | 2006-03-28 | 2006-05-10 | Novartis Ag | Organic compounds |
| PL2007756T3 (pl) | 2006-04-07 | 2016-01-29 | Vertex Pharma | Modulatory transporterów posiadających kasetę wiążącą ATP |
| WO2007129188A1 (en) | 2006-05-10 | 2007-11-15 | Pfizer Japan Inc. | Cyclopropanecarboxamide compound |
| US20080039535A1 (en) | 2006-08-14 | 2008-02-14 | Wyeth | Methods of identifying agents for treating neurological disorders |
| US8497271B2 (en) | 2009-10-07 | 2013-07-30 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
| US8426414B2 (en) | 2009-10-09 | 2013-04-23 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
-
2010
- 2010-10-05 US US12/898,016 patent/US8304577B2/en active Active
- 2010-10-06 WO PCT/US2010/051614 patent/WO2011044225A1/en not_active Ceased
- 2010-10-06 CN CN2010800454127A patent/CN102656145A/zh active Pending
- 2010-10-06 EP EP10763963.5A patent/EP2486011B1/en not_active Not-in-force
- 2010-10-06 JP JP2012533276A patent/JP2013507374A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013507374A5 (enExample) | ||
| JP2013507371A5 (enExample) | ||
| CY1121781T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης της ρασαγιλινης και χρησεις αυτων | |
| JP2013507369A5 (enExample) | ||
| JP2019537570A5 (enExample) | ||
| JP2017509586A5 (enExample) | ||
| CY1122610T1 (el) | Αλκοξυ πυραζολια ως ενεργοποιητες διαλυτης γουανυλικης κυκλασης | |
| JP2014051526A5 (enExample) | ||
| JP2013537203A5 (enExample) | ||
| JP2019518766A5 (enExample) | ||
| EA201291220A1 (ru) | Производные аминопиримидина в качестве модуляторов lrrk2 | |
| BRPI0820112B8 (pt) | derivados de isoxazol-piridina, seu uso e processos de preparação e medicamento | |
| JP2014511892A5 (enExample) | ||
| EA200901373A1 (ru) | Аминогетероциклические соединения | |
| JP2017533968A5 (enExample) | ||
| JP2017504635A5 (enExample) | ||
| JP2017511321A5 (enExample) | ||
| JP2016503797A5 (enExample) | ||
| CY1118314T1 (el) | Συνδυασμοι αγωνιστων υποδοχεα σεροτονινης για την αγωγη κινητικων διαταραχων | |
| CY1116452T1 (el) | Θετικοι αλλοστερικοι ρυθμιστες μ1 υποδοχεα του τυπου πυρανυλ αρυλ μεθυλ βενζοκιναζολινονης | |
| JP2017517538A5 (enExample) | ||
| TN2016000452A1 (en) | Heteroaromatic compounds and their use as dopamine d1 ligands. | |
| JP2018530582A5 (enExample) | ||
| JP2017502063A5 (enExample) | ||
| PH12016501993A1 (en) | Heteroaromatic compounds and their use as dopamine d1 ligands |